The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A study on thromboembolism of patients with pancreatic cancer.
 
Kwan Yu LAM
No Relationships to Disclose
 
Kirsty Lee
No Relationships to Disclose
 
Charing Chong
No Relationships to Disclose
 
Anthony WH Chan
No Relationships to Disclose
 
Tony Mok
Employment - The Chinese University of Hong Kong
Leadership - Sanomics Limited
Stock and Other Ownership Interests - Sanomics Limited
Honoraria - ACEA Biosciences; Amgen; AstraZeneca; Aveo/Biodesix; Biomarin; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Oncogenex; Pfizer; Prime Oncology; Roche/Genentech; SFJ Pharmaceuticals Group; Vertex
Consulting or Advisory Role - ACEA Biosciences; Amgen; AstraZeneca; Aveo/Biodesix; Biomarin; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; geneDecode; Janssen; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Oncogenex; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Vertex
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Janssen; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Prime Oncology; Roche/Genentech
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SFJ Pharmaceuticals Group (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Merck Serono; Novartis; Pfizer; Roche
 
Stephen Lam Chan
Consulting or Advisory Role - MSD Oncology; Novartis
Research Funding - Novartis